The progress of mother-to-child transmission of Human Immunodeficiency Virus (HIV) after Dolutegravir (DTG) optimization program: evidence from a multicenter cohort study in Ethiopia.

Those women who used the DTG-based ART regimen had a lower risk of perinatal (P-value, 0.471), breastfeeding (P-value, 0.463) and end-of-care MTCT (P-value, 0.684) than did those who used the EFV-based regimens, although these differences did not reach statistical significance (Fig. 5 a-c).

also in 111,027 other papers